lily glp 1 The GLP-1 market is projected to exceed 100B USD by 2030 Lilly to pour $6.5 billion

Many patients experience a reduced appetite, an extra energy boost, and enhanced motivation

Injectable GLP-1s may be more suitable for: Patients aiming for the maximum possible reduction in body weight, those with co-existing conditions like heart disease or chronic kidney disease (due to specific FDA approvals for Ozempic), or those who prefer a simple weekly medication schedule

Less frequent injections could significantly improve adherence for people who find weekly injections burdensome

Ozempic, Wegovy, and Mounjaro only work as long as youre taking them

cAMP signaling stimulates PKA and EPAC, both of which contribute to the production and release of insulin (Yang and Yang, 2016)

doi: 10.3389/fendo.2023.1146680 63 BarbaraDWHannonJDHartmanWR